UNITED STATES: Hospitalizations of Pregnant HIV-Infected Women in the USA Prior to and During the Era of HAART, 1994-2003

Important note: Information in this article was accurate in 2006. The state of the art may have changed since the publication date.

UNITED STATES: Hospitalizations of Pregnant HIV-Infected Women in the USA Prior to and During the Era of HAART, 1994-2003

AIDS Vol. 20; No. 14: P. 1823-1831 (09.11.06) - Friday, December 29, 2006
Athena P. Kourtis; Pooja Bansil; Melissa McPheeters; Susan F. Meikle; Samuel F. Posner; Denise J. Jamieson

In noting that "the literature on whether HIV infection and its complex antiretroviral treatments confer a higher risk for adverse pregnancy outcomes is controversial," the authors of the current study set out to compare rates of hospitalization for select morbidities among HIV-infected and uninfected pregnant women in the United States.

Data from the 1994-2003 Nationwide Inpatient Sample were employed. Descriptive statistics and multivariate logistic regression were used to examine socio-demographic characteristics, morbidity outcomes, and time trends.

Annually, there were approximately 6,000 hospitalizations of HIV-infected pregnant women. HIV-positive women were more likely to be hospitalized in urban hospitals, in the South, have Medicaid as the expected payer, have longer hospitalizations, and incur higher charges than uninfected women. Compared to their uninfected counterparts, pregnant HIV-infected women were more frequently hospitalized for major puerperal sepsis, genitourinary infections, influenza, bacterial infections, preterm labor/delivery and liver disorders. However, there was no significant difference in rates of pre-eclampsia and antepartum hemorrhage between the two groups. Though rates of inpatient mortality and various infectious conditions decreased from 1994 to 2003, the rate of gestational diabetes among HIV-positive pregnant women increased.

"HIV-infected pregnant women in the USA continue to be at higher risk for morbidity and adverse obstetric outcomes," the authors concluded. "With the introduction of antiretroviral therapy, rates of most of the conditions examined have either decreased or remained stable, hence current antiretroviral regimens do not seem to be associated with major adverse pregnancy outcomes on a population basis. The increase in gestational diabetes among HIV-infected women may be associated, in part, with antiretroviral therapy and merits further attention."
061229
AD062524

Copyright © 2006 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 2006. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2006. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.